DCGO Stock Recent News
DCGO LATEST HEADLINES
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in August and September: Three Part Advisors Midwest (August 26th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Tuesday August 26th at 11:30 AM CT. A webcast of the event will be available on.
DocGo Inc. (NASDAQ:DCGO ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Lee Bienstock - CEO & Director Mike Cole - Vice President of Investor Relations Norman Rosenberg - Treasurer & CFO Conference Call Participants Aditya Dagaonkar - Unidentified Company Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Second Quarter Earnings Conference Call. [Operator Instructions] This call is being recorded on Thursday, August 7, 2025.
DocGo Inc. (DCGO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.06 per share a year ago.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced a new contract with one of the largest academic medical systems in the New York metro area. Through this contract, DocGo's dispatchers located within the health system's discharge management office will use DocGo's proprietary transportation management software for centralized management of all discharges acr.
SAN FRANCISCO , Aug. 4, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP reminds DocGo Inc. (NASDAQ: DCGO) investors that the firm is investigating potential legal claims relating to alleged false statements about the educational background of DocGo's former CEO and the company's business development efforts, and about $4 million in insider stock sales. Current shareholders are encouraged to contact the firm.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that it secured a new contract to begin facilitating a range of community vaccination services for The County of San Diego, California. Designed to expand access to care for underserved populations in San Diego's East and North-Central neighborhoods, this comprehensive program will be held in coordination wit.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the second quarter ended June 30, 2025 after the markets close on Thursday, August 7, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, August 7, 2025 5:.
SAN FRANCISCO , July 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises DocGo Inc. (NASDAQ: DCGO) investors that the firm is investigating potential legal claims relating to alleged false statements about the educational background of DocGo's former CEO and the company's business development efforts. Current shareholders are encouraged to contact us.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its Ambulnz subsidiary was awarded a multi-year $3.4 million contract to provide medical transportation services to the Albany Stratton VA Medical Center. Under the contract, Ambulnz by DocGo will provide basic life support, advanced life support and critical care ambulance services for patients needing.